1. HBW Insight
  2. >>Health
  3. >>Policy & Regulation
  4. >>Legal

US FDA Takes Star Turn In Recent Drug Ingredient Liability Lawsuits

Interjection In Zantac MDL Is Agency's Second In Past Year

 
• By Brenda Sandburg

Agency’s direct involvement in pharma product liability litigation is one of the most striking developments in the field over the past year; 16 cases in multidistrict litigation listed in chart showing status of settlements and upcoming bellwether trials.

Pharma litigation

A dispute over plaintiffs’ access to results of a Zantac (ranitidine) study sponsored by the US Food and Drug Administration illustrates how parties in multidistrict litigation are trying to get the agency to bolster their positions.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal

More from Policy & Regulation